Société PharmaCyte Biotech, Inc. Other OTC
Actions
PMCB
US71715X1046
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/01/15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/08/20 |
Lilli Brandtner
PRN | Corporate Officer/Principal | - | 10/02/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/11/22 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/12/22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/01/15 |
Director/Board Member | 50 | 15/08/22 | |
Director/Board Member | 65 | 10/07/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 21 604 315 | 7 767 289 ( 35,95 %) | 13 150 919 ( 60,87 %) | 35,95 % |
Action B | 0 | 35 000 | 0 | 0 |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
FEMASYS INC. -.--% | 0 | -.--% | 0 $ |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+26,08% | 662 Md | |
+21,85% | 546 Md | |
-4,77% | 359 Md | |
+16,97% | 323 Md | |
+5,69% | 290 Md | |
+13,68% | 234 Md | |
+3,65% | 198 Md | |
-11,12% | 194 Md | |
+8,08% | 167 Md |